Skip to content

Ferinject Intravenous Injection 500mg General Use Result Survey

Ferinject Intravenous Injection 500mg General Use Result Survey

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT2031240252
Enrollment
1000
Registered
2024-08-06
Start date
2021-09-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anaemia

Interventions

None listed

Sponsors

Contact for Pharmacovigilance
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with iron deficiency anaemia who were treated Ferinject.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Adverse event

Contacts

Public ContactPharmacovigilance Contact for

ZERIA Pharmaceutical Co., Ltd.

iyakujo@zeria.co.jp+81-3-3663-2362

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026